Table 2. Socio demographic, motivation & sexual risk characteristics of participants in observational study, stratified by consent to participate in HIV vaccine trial.
| Characteristic | Total (N = 86) |
Consented to actual vaccine trial (n = 26) |
Did not consent to trial (n = 60) |
P = value | |||
|---|---|---|---|---|---|---|---|
| n | % | n | (%) | n | (%) | ||
| Gender | |||||||
| Male | 41 | (47.7) | 16 | (61.5) | 25 | (41.7) | 0.09 |
| Female | 45 | (52.3) | 10 | (38.5) | 35 | (58.3) | |
| Age group | |||||||
| 18–27 | 58 | (67.4) | 18 | (69.2) | 40 | (66.7) | 0.59 |
| 28–37 | 24 | (27.9) | 6 | (23.1) | 18 | (30.0) | |
| 38 and above | 4 | (4.7) | 2 | (7.7) | 2 | (3.3) | |
| Marital Status | |||||||
| Single never married | 46 | (53.5) | 14 | (53.8) | 32 | (53.3) | 0.87 |
| Married | 35 | (40.7) | 11 | (42.3) | 24 | (40.0) | |
| Single ever married | 5 | (5.8) | 1 | (3.8) | 4 | (6.7) | |
| Occupation | |||||||
| Student | 28 | (32.6) | 7 | (26.9) | 21 | (35.0) | 0.58 |
| Self-employed | 26 | (30.2) | 9 | (34.6) | 17 | (28.3) | |
| Employed | 21 | (24.4) | 8 | (30.8) | 13 | (21.7) | |
| Unemployed | 11 | (12.8) | 2 | (7.7) | 9 | (15.0) | |
| Health-status | |||||||
| Excellent | 18 | (20.9) | 6 | (23.1) | 12 | (20.0) | 0.93 |
| Good | 62 | (72.1) | 18 | (69.2) | 44 | (73.3) | |
| Average | 6 | (7.0) | 2 | (7.7) | 4 | (6.7) | |
| Main reason for hypothetical willingness to participate | |||||||
| Altruism | 32 | (37.2) | 12 | (46.2) | 20 | (33.3) | 0.23 |
| Learn response to vaccine | 22 | (25.6) | 3 | (11.5) | 19 | (31.7) | |
| Presumptive protection against HIV | 17 | (19.8) | 5 | (19.2) | 12 | (20.0) | |
| Other | 15 | (17.4) | 6 | (23.1) | 9 | (15.0) | |
| Be a hero | 2 | (2.3) | 2 | (7.7) | 5 | (8.3) | |
| Interest in research | 1 | (1.2) | 1 | (3.8) | 3 | (5.0) | |
| Learn their health status | 1 | (1.2) | 1 | (3.8) | 1 | (1.7) | |
| No response/no answer | 2 | (2.3) | 2 | (7.7) | 0 | (0.0) | |
| Sexually active | 0.93 | ||||||
| Yes | 59 | (68.6) | 18 | (69.2) | 41 | (68.3) | |
| No (duration:) | 27 | (31.4) | 8 | (30.8) | 19 | (31.7) | 0.96 |
| 1–5 months | 13 | (15.1) | 4 | (15.4) | 9 | (15.0) | |
| 6–10 months | 6 | (7.0) | 2 | (7.7) | 4 | (6.7) | |
| 11–15 months | 4 | (4.7) | 1 | (3.8) | 3 | (5.0) | |
| Never had sex | 4 | (4.7) | 1 | (3.8) | 3 | (5.0) | |
| Sexual partners in the last one year | 0.57 | ||||||
| None | 10 | (11.6) | 2 | (7.7) | 8 | (13.3) | |
| 1 | 53 | (61.6) | 16 | (61.5) | 37 | (61.7) | |
| 2 | 14 | (16.3) | 4 | (15.4) | 10 | (16.7) | |
| ≥ 3 | 9 | (10.5) | 4 | (15.4) | 5 | (8.3) | |
| Number of casual partners | 0.64 | ||||||
| None | 75 | (87.2) | 23 | (88.5) | 52 | (86.7) | |
| 1 | 6 | (7.0) | 1 | (3.8) | 5 | (8.3) | |
| 2 | 4 | (4.7) | 2 | (7.7) | 2 | (3.3) | |
| ≥ 3 | 0 | 0 | (0.0) | 1 | (1.7) | ||
| Condom use with casual partners | 0.72 | ||||||
| No casual partners | 75 | (87.2) | 23 | (88.5) | 52 | (86.7) | |
| Never | 2 | (2.3) | 1 | (3.8) | 1 | (1.7) | |
| Always | 9 | (10.5) | 2 | (7.7) | 7 | (11.7) | |
| Injection drug use (IDU) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | |
| Sexual partner with IDU | 0.51 | ||||||
| No sexual partner | 4 | (4.7) | 1 | (3.8) | 3 | (5.0) | |
| No | 66 | (76.7) | 22 | (84.6) | 44 | (73.3) | |
| Don’t know | 16 | (18.6) | 3 | (11.5) | 13 | (21.7) | |
| STI in last six months | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | |
| HIV+ sexual partner | 0.97 | ||||||
| Never had sexual partner | 4 | (4.7) | 1 | (3.8) | 3 | (5.0) | |
| No | 79 | (91.9) | 24 | (92.3) | 55 | (91.7) | |
| Don’t know | 3 | (3.5) | 1 | (3.8) | 2 | (3.3) | |